LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M
Supporting its next series A round up to € 50 M LinKinVax, a clinical-stage biotechnology company, is announcing capital funding for a total of €7,3 M from several individual tech executive investors including the co-founder André-Jacques Auberton-Hervé …